Related Experiment Video
Updated: Mar 30, 2026

Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
Modeling mania in preclinical settings: A comprehensive review.
Ajaykumar N Sharma1, Gabriel R Fries2, Juan F Galvez3
1Center for Translational Psychiatry, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA; Center of Excellence on Mood Disorders, Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, USA.
Current animal models for mania lack validity and fail to capture bipolar disorder (BD) neuroprogression. Novel genetic models and adapted paradigms show promise for better understanding manic episodes.
Area of Science:
- Neuroscience
- Psychiatry
- Animal Models
Background:
- Understanding the pathophysiology of bipolar disorder (BD) manic episodes is limited.
- Existing animal models for mania possess restricted face, construct, and predictive validity.
- Current models do not integrate recent pathophysiological frameworks like neuroprogression in BD.
Purpose of the Study:
- To review the history, validity, and limitations of current animal models for mania.
- To explore novel genetic models, including knockout mice for key signaling pathways.
- To examine recent trends in preclinical models for understanding BD's neuroprogressive and recurrent nature.
Main Methods:
- Literature review of existing and novel animal models for mania.
- Analysis of genetic models targeting neurotransmission, synapse formation, and intracellular signaling.
- Evaluation of models in the context of neuroprogression and recurrence in BD.
Main Results:
- The validity of current animal models for mania remains significantly limited.
- Novel genetic models, such as knockout mice, offer potential improvements.
- Adaptation of existing paradigms may also enhance preclinical research.
Conclusions:
- Existing animal models for mania have substantial limitations in validity and scope.
- Novel approaches, particularly genetic models, show promise for advancing research.
- Further development and adaptation of preclinical models are crucial for understanding BD.

